Newbridge Financial Services Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $275 Million
- Q3 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 151 shares of REGN stock, worth $117,553. This represents 0.06% of its overall portfolio holdings.
Number of Shares
151
Previous 141
7.09%
Holding current value
$117,553
Previous $148,000
6.76%
% of portfolio
0.06%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.26 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.58 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.83 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.82 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.35 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $83.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...